DNA levels in circulating immune complexes decrease at severe SLE flares - Correlation with complement component C1q

被引:29
作者
Bengtsson, A [1 ]
Nezlin, R
Shoenfeld, Y
Sturfelt, G
机构
[1] Univ Lund Hosp, Dept Rheumatol, S-22105 Lund, Sweden
[2] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel
[3] Shaim Sheba Med Ctr, Tel Hashomer, Israel
关键词
anti-DNA; C1q; DNA; immune complex; SLE;
D O I
10.1006/jaut.1999.0300
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to investigate the relationship of DNA content in circulating immune complexes with disease course and activity in SLE. The DNA content in circulating immune complexes containing anti-DNA antibodies of IgG class was determined in serial samples from 28 patients with SLE by a quantitative immunochemical assay. The patients presented various active disease manifestations over 5-55 months. Disease activity (SLEDAI-score), drug treatment and ACR-criteria were recorded. Levels of anti-dsDNA, CRP, leukocytes, complement components C3, C4 and C1q were measured. Patients with severe flares and high SLEDAI scores had low C1q levels at onset of active disease manifestations. The patients with low C1q serum levels during flare (n = 13) had significantly lower amounts of DNA in immune complexes than patients with normal C1q (P = 0.001). Levels of DNA in immune complexes correlated with C1q at flares (r = 0.62, P < 0.0001) and correlated inversely with SLEDAI scores (r = -0.47, P = 0.012). in conclusion, the low levels of DNA in circulating immune complexes found in severely ill SLE patients with concomitantly low serum concentrations of C1q prior to flares might be related to tissue deposition of immune complexes. (C) 1999 Academic Press.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 34 条
  • [1] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [2] Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
    Botto, M
    Dell'Agnola, C
    Bygrave, AE
    Thompson, EM
    Cook, HT
    Petry, F
    Loos, M
    Pandolfi, PP
    Walport, MJ
    [J]. NATURE GENETICS, 1998, 19 (01) : 56 - 59
  • [3] BOWNESS P, 1994, Q J MED, V87, P455
  • [4] The lupus paradox
    Carroll, MC
    [J]. NATURE GENETICS, 1998, 19 (01) : 3 - 4
  • [5] AUTOANTIGENS TARGETED IN SYSTEMIC LUPUS-ERYTHEMATOSUS ARE CLUSTERED IN 2 POPULATIONS OF SURFACE-STRUCTURES ON APOPTOTIC KERATINOCYTES
    CASCIOLAROSEN, LA
    ANHALT, G
    ROSEN, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1317 - 1330
  • [6] IMMUNE-COMPLEX PROCESSING IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - INVIVO IMAGING AND CLEARANCE STUDIES
    DAVIES, KA
    PETERS, AM
    BEYNON, HLC
    WALPORT, MJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 2075 - 2083
  • [7] Gilbert D, 1997, REV RHUM, V64, P210
  • [8] JOHNSON U, 1983, ACTA PATH MICRO IM C, V91, P147
  • [9] Complement receptor type 1 (CR1, CD35) is a receptor for C1q
    Klickstein, LB
    Barbashov, SF
    Liu, T
    Jack, RM
    NicholsonWeller, A
    [J]. IMMUNITY, 1997, 7 (03) : 345 - 355
  • [10] Korb LC, 1997, J IMMUNOL, V158, P4525